Molecular cytogenetic analysis of dicentric chromosomes in acute myeloid leukemia

Leuk Res. 2016 Apr:43:51-7. doi: 10.1016/j.leukres.2016.01.001. Epub 2016 Jan 8.

Abstract

Dicentric chromosomes (DCs) have been described in many hematological diseases, including acute myeloid leukemia (AML). They are markers of cancer and induce chromosomal instability, leading to the formation of other chromosomal aberrations and the clonal evolution of pathological cells. Our knowledge of the roles and behavior of human DCs is often derived from studies of induced DCs and cell lines. It is difficult to identify all the DCs in the karyotypes of patients because of the limitations of metaphase cytogenetic methods. The aim of this study was to revise the karyotypes of 20 AML patients in whom DCs were found with conventional G-banding or multicolor fluorescence in situ hybridization (mFISH) with (multi)centromeric probes and to characterize the DCs at the molecular cytogenetic level. FISH analyses confirmed 23 of the 29 expected DCs in 18 of 20 patients and identified 13 others that had not been detected cytogenetically. Fourteen DCs were altered by other chromosomal changes. In conclusion, karyotypes with DCs are usually very complex, and we have shown that they often contain more than one DC, which can be missed with conventional or mFISH methods. Our study indicates an association between number of DCs in karyotype and very short survival of patients.

Keywords: Acute myeloid leukemia; Centromere; Chromosome rearrangement; Dicentric chromosome; Fluorescence in situ hybridization.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abnormal Karyotype*
  • Aged
  • Aged, 80 and over
  • Cell Line, Tumor
  • Chromosomes, Human / genetics*
  • Disease-Free Survival
  • Female
  • Humans
  • In Situ Hybridization, Fluorescence*
  • Leukemia, Myeloid, Acute / genetics*
  • Leukemia, Myeloid, Acute / mortality*
  • Male
  • Middle Aged
  • Survival Rate